In the News

Kai-Ming Fu, MD, PhD
Kai-Ming Fu, MD, PhD, has been named chief of neurological surgery at the newly expanded Weill Cornell Medicine Lower Manhattan Spine Center.
Dr. K. Daniel Riew
“The addition of Dr. Riew to our team further underscores the immense talent that we have here at the Center for Comprehensive Spine Care,” says Dr. Roger Härtl.
Neurosurgery Award Winners

The Neurological Surgery Outstanding Service Award has taken even more meaning this year during the pandemic. The award spotlights members of the department who go above and beyond their assigned duties and who exemplify the core values of the department, including collegiality/teamwork, compassion, perseverance/commitment, and leadership.

We wish we could bestow 150 of these awards, given how many individuals went above and beyond, but we singled out three whose efforts stood out in...

Dr Jared Knopman, Weill Cornell Medicine
Dr. Jared Knopman, who has been a pioneer in the use of middle meningeal artery embolization for subdural hematomas, will lead a new FDA-approved clinical trial of the procedure.
John Park, MD, PhD, has joined the faculty of Weill Cornell Medicine as Chief of Neurological Surgery at NewYork-Presbyterian Queens
Dr. Park takes on the leadership of a neurosurgical team that provides world-class care for all conditions of the brain and spine to more than 2.3 million residents of Queens.
Automated Tumor Preservation System from Nico
In this study, Dr. Ramakrishna and team aim to understand how tissue processing in the pre-analytic phase affects downstream tissue analyses.
U.S. News Best Hospitals 2020
The annual hospital rankings from US News & World Report are out, and once again NewYork-Presbyterian Hospital has been named the best in New York.
Rohan Ramakrishna, MD, Weill Cornell Medicine

The William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma at NewYork-Presbyterian has awarded a quarter-million-dollar seed grant to Dr. Rohan Ramakrishna, Dr. Howard Fine, and Dr. Dan-Avi Landau to study the impact of genetic alterations on cellular states in...

From 2012 to 2020, Weill Cornell Medicine conducted an FDA-approved research study for idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri. This innovative trial tested the effectiveness of stent placement in patients with severe intracranial hypertension who had not responded to other treatments.
Rohan Ramakrishna, MD, Weill Cornell Medicine
"Across our missions of clinical care, research, and education we will ensure that Brooklyn residents receive world-class neurosurgical attention right at home.”

Weill Cornell Medicine Neurological Surgery 525 East 68 Street, Box 99 New York, NY 10065 Phone: 866-426-7787